JLM-BioCity is holding its next event on Orphan Drugs from a regulatory, business and investor’s perspective, with several pharma companies sharing their experiences.
Invited speakers are:
* Yuval Cabilly, General Partner, Israel Biotech Fund
* Techiya Toaff, Director, Regulatory Affairs, Navon Pharma Group
* Alon Bloomenfeld, CEO & co-founder, Raziel Therapeutics
* Yael Gruenbaum, Director, Medison Ventures
Come and join us to hear inspiring and exceptional anecdotes!
ttps://
https://lnkd.in/dqgAyrPTo get entrance to the campus and a parking space, pl fill the form below IN HEBREW